Why is Vista Pharma. falling/rising?

As of 16-Jul, Vista Pharmaceuticals Ltd's stock price is currently at 11.30, reflecting an increase of 0.08 or 0.71%. The stock has outperformed its sector by 0.98% today, although it has shown a decline of 0.35% over the past week and a more significant drop of 3.42% over the past month. Despite being higher than its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below the 200-day moving average. The company faces challenges, including operating losses and a weak long-term fundamental strength, with net sales declining at an annual rate of -15.02% over the last five years. Additionally, the stock's negative EBITDA and poor EBIT to interest ratio indicate financial instability, contributing to its recent price movements.
In the broader market context, the Sensex has declined by 1.08% over the past week and increased by 1.02% over the past month, indicating that Vista Pharmaceuticals is not only underperforming against the market but also against its historical performance, with a year-to-date decline of 4.07% compared to the benchmark's gain of 5.75%. The stock has significantly underperformed the market over the last year, generating a return of -27.00% while the broader market has seen a modest increase of 0.47%. This underperformance, combined with falling investor participation and liquidity concerns, suggests that the stock's recent rise may not be sustainable in the face of its ongoing financial difficulties.